APELLIS PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K)

1-07">8-K
 
 CURRENT REPORT
 Pursuant to Section 13 or 15(d)
 of the Securities Exchange Act of 1934
 Date of Report (Date of earliest event reported): January 7, 2020
 
Apellis Pharmaceuticals, Inc.
 (Exact Name of Registrant as Specified in its Charter)
 
Delaware
 
 Share
        

                                            © Acquiremedia - 2020